Weight loss after RYGB surgery for obesity without/with T2DM reduced fasting and/or postprandial plasma LEAP2 at 3 to 24 months after 16% to 31% weight loss [17, 34]. The gene discussed is LEAP2; the disease is obesity due to melanocortin 4 receptor deficiency.